Coldplasmatech
COLDPLASMATECH GmbH is a Greifswald-based medical-technology company that commercializes the patented Active Glow® cold-plasma system (CPTcube + CPTpatch) — the first active wound dressing — for treating chronic wounds and burns in DACH-region hospitals, burn centers, and certified Plasma Competence Centers.
- Company typePrivate
- Founded2015
- HeadquartersGreifswald, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Coldplasmatech does
COLDPLASMATECH GmbH is a privately held German medical-technology company, headquartered in Greifswald, that develops and commercializes the world's first active wound dressing (CPT®patch) using cold physical plasma for the treatment of chronic and complex wounds. The company is a spin-off from the Leibniz Institute for Plasma Research e.V. (INP), built on research from the BMBF-funded 'plasmatis' center, and operates its patented Active Glow® technology that generates body-temperature plasma inside a sealed patch, delivering antimicrobial and wound-healing effects (including Log8 bacterial load reduction and clinically demonstrated 214% wound closure improvement versus standard therapy in the BMBF-funded POWER study).
The product system consists of two EU MDR Class IIb-certified medical devices: the CPT®cube, a fully automatic single-button control unit that powers the plasma generation, and the CPT®patch, a single-use sterile active wound dressing sold in boxes of 10 and applied for ~2 minutes per treatment, with a typical course of 6–10 sessions over 4–5 weeks. Coldplasmatech monetizes through capital equipment sales of CPTcubes to hospitals, burn centers, and certified Plasma.Kompetenz.Zentren, complemented by recurring consumable (CPTpatch) revenue and training/certification services. Distribution is primarily direct enterprise sales in the DACH region (Germany, Switzerland, Austria), with a March 2025 strategic partnership with Royal Biologics signaling intent to expand channels beyond Europe.
The company targets hospital burn centers, plastic/reconstructive surgery departments, specialized wound care centers, and nursing services treating severe burns, chronic leg ulcers, diabetic foot syndrome, pressure ulcers, and wounds infected with multi-resistant bacteria (including MRSA). Named customers include Hannover Medical School, BG Bergmannstrost Halle, Munich Bogenhausen, Cologne Children's Hospital Riehl, Schleswig-Holstein University Hospital, BG Murnau, Graz University Hospital, Rehab Clinic Bellikon (Switzerland), and Martin Luther Krankenhaus Berlin, with certification/clinical awards including the German Innovation Award (2018), EY Public Value Award (2016), MedTech CEO of the Year — Dr. Carsten Mahrenholz (2022), and Innovation Award Bavaria (2023).
Coldplasmatech firmographics
Firmographics- Name
- Coldplasmatech
- Legal name
- COLDPLASMATECH GmbH
- Website
- https://coldplasmatech.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- COLDPLASMATECH GmbH is a Greifswald-based medical-technology company that commercializes the patented Active Glow® cold-plasma system (CPTcube + CPTpatch) — the first active wound dressing — for treating chronic wounds and burns in DACH-region hospitals, burn centers, and certified Plasma Competence Centers.
- Ownership category
- akta.pro rank
Coldplasmatech industry classification
Industry- Product category
- Medical Devices - Cold Plasma Wound Care
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industries
- Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation) (HLAHALAC), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where Coldplasmatech is headquartered
LocationHeadquarters
- HQ city
- Greifswald
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Coldplasmatech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- CPT®cube Device Sales: The CPT®cube (control device) is sold as a capital medical device to treatment centers and healthcare facilities. Initial installation includes training and onboarding.
- CPT®patch Consumables: CPT®patches are single-use sterile wound dressings sold in boxes of 10. These are the recurring consumable revenue stream as patients require multiple treatments (typically 6-10 treatments over 4-5 weeks).
- Training and Certification Services: Initial installation includes instruction and training for new CPT®cube customers. The company offers certification as a CPT® Plasma.Kompetenz.Zentrum for qualifying treatment centers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | CPT®patch (single-use wound dressing, box of 10) |
| Other | Multi-year contract | CPT®cube with initial installation and training |
| Other | Pay-as-you-go | Additional CPT®cubes (after initial installation) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Coldplasmatech product offering
Product offeringCore offering
COLDPLASMATECH develops and sells the first active wound dressing system for chronic wound treatment using cold physical plasma. The CPT® system consists of the CPT®cube control device and single-use CPT®patch wound dressings, sold to hospitals, burn centers, wound care clinics, and certified treatment centers across Germany and parts of Europe.
Product overview
Coldplasmatech offers a wound therapy system consisting of two certified Class IIb medical devices: the CPT®cube (fully automatic control device) and the CPT®patch (active wound dressing). These products work together using the patented ACTIVE GLOW® technology to deliver cold plasma therapy for chronic wound treatment. The CPT®cube controls the plasma generation while the CPT®patch delivers the plasma to the wound surface. Treatment takes approximately 2 minutes and can be administered by non-medical personnel. The company operates through a network of certified CPT® Plasma Competence Centers.
Differentiator
Problem solved
Functional benefit
Products and services
- CPT®cube Fully automatic Class IIb-certified control device that generates cold physical plasma for wound therapy. Operates at optimal effect level with single 'Home' button activation and completes treatments in approximately 2 minutes. Sold as a capital medical device to hospitals, burn centers, wound care facilities, and certified CPT® Plasma.Kompetenz.Zentren; initial installation includes training and onboarding.
- CPT®patch Active wound dressing (plasma patch) for treatment of chronic wounds using cold physical plasma. Sterile single-use patches sold in boxes of 10, covering treatment areas from 0–100 cm², depth-independent application, and combinable with negative pressure therapy and artificial skin replacement. Forms the recurring consumable revenue stream as patients typically require 6–10 treatments over 4–5 weeks.
- CPT® Plasma.Kompetenz.Zentrum Certification Program Certification program for healthcare facilities (hospitals, burn units, wound care centers, nursing services) to become authorized CPT® Plasma.Kompetenz.Zentren. Certified centers receive training, meet quality standards, and are authorized to deliver CPT cold plasma therapy to patients with chronic wounds.
Quantifiable outcome
- 214% wound closure factor compared to standard wound therapy (SWT) group in POWER study
- +4 more outcomes
Companies that use Coldplasmatech
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles2 records
Coldplasmatech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Coldplasmatech partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Royal BiologicscoreStrategic partnership announced in March 2025 representing a new milestone for Coldplasmatech. The partnership with Royal Biologics likely involves distribution or co-development of cold plasma therapy products.
- Leibniz Institute for Plasma Research e.V. (INP)coreColdplasmatech emerged as a spin-off from the Leibniz Institute for Plasma Research e.V. (INP) in Greifswald. The company built its development work on results from the Center for Innovation Competence 'plasmatis' at INP, which has been funded by the German Federal Ministry of Education and Research since 2008.
- CPT® Plasma.Kompetenz.Zentren (Certified Treatment Centers)coreNetwork of certified treatment centers that meet Coldplasmatech's standards for providing CPT cold plasma therapy. Centers include hospitals, burn units, and specialized wound care facilities that undergo certification to become authorized CPT providers.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Coldplasmatech competitors and assessment
Company assessmentEmerging players
- Relyon Plasma: German specialist in cold plasma technology and equipment. Adjacent competitor with overlapping cold-plasma IP base and a presence in Germany.
- Apyx Medical: Medical device company commercialising plasma-based surgical and cosmetic technologies. Adjacent in cold plasma use cases though focused on surgical/energy rather than chronic wounds.
Broad incumbents
- ConvaTec: Major wound and ostomy care player (Aquacel, DuoDERM). Targets the same chronic-wound patient population in hospitals and home care settings.
- 3M Health Care (Medical Solutions): Broad medical products incumbent including advanced wound care (Tegaderm). Competes for hospital wound-care shelf space and formulary slots in the same customer base.
- Mölnlycke Health Care: Global leader in wound care and surgical solutions (Mepilex, Avance, etc.). Competes indirectly by being the dominant supplier of advanced wound dressings in the same hospitals Coldplasmatech targets.
- Smith & Nephew (Advanced Wound Management): Large incumbent in advanced wound care (Allevyn, PICO). Competes for hospital formulary inclusion alongside Coldplasmatech's CPT®patch.
- Coloplast: Global wound and skin care company with a strong chronic-wound portfolio (Biatain, Conveen). Competes for the same hospital and outpatient wound-care budgets.
Direct peers
- Organogenesis: US regenerative medicine company (Apligraf, Dermagraft) selling skin substitutes and active wound healing biologics. Closely comparable in the 'active wound healing' positioning even though delivery mechanism differs.
- MiMedx: US-based developer of placental tissue allografts for wound healing and surgical recovery. Comparable regenerative wound-care positioning to Coldplasmatech's active wound healing claims.
- Plasmacure: Dutch developer of cold plasma technology for chronic wound healing. Most direct competitor in plasma-based wound therapy, targeting similar indications with overlapping clinical positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Coldplasmatech social profiles
Digital presenceColdplasmatech compliance and trust
Trust signalCompliance1 record
Coldplasmatech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Coldplasmatech leadership team
Management profileNumber of profiles
Profiles3 records
Coldplasmatech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Coldplasmatech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Coldplasmatech
What does Coldplasmatech do?
COLDPLASMATECH develops and sells the first active wound dressing system for chronic wound treatment using cold physical plasma. The CPT® system consists of the CPT®cube control device and single-use CPT®patch wound dressings, sold to hospitals, burn centers, wound care clinics, and certified treatment centers across Germany and parts of Europe.
Is Coldplasmatech a public or private company?
Coldplasmatech is a private company. It is classified as venture growth investor backed and is currently operating.
When was Coldplasmatech founded?
Coldplasmatech was founded in 2015. It employs 11 to 50 people.
Where is Coldplasmatech based?
Coldplasmatech is headquartered in Greifswald, Germany, in the Europe region.
How does Coldplasmatech make money?
Three revenue lines are on record. CPT®cube Device Sales are the primary driver. The others are CPT®patch Consumables and training and Certification Services.
Who are Coldplasmatech's main competitors?
Emerging players on record are Relyon Plasma and Apyx Medical. Broad incumbents are ConvaTec, 3M Health Care (Medical Solutions), Mölnlycke Health Care, Smith & Nephew (Advanced Wound Management) and Coloplast. Direct peers are Organogenesis, MiMedx and Plasmacure.
Does Coldplasmatech have an API?
No public API is recorded for Coldplasmatech.
What industry is Coldplasmatech in?
Coldplasmatech's product category is Medical Devices - Cold Plasma Wound Care. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAHALAC, Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation). Its NAICS code is 334510 and its SIC code is 3845.